Podcast

Rheumatology Biologics Registries

This podcast discusses the importance of clinical rheumatology biologics registries.

In the latest installment in the podcast series created by the journal Rheumatology, Robert Moots and David Isenberg “discuss registries, what they are, their aims and outcomes,” highlighting the British Society for Rheumatology Biologics Register (the largest biologics register in the world,) “detailing its design, aims and findings.” This podcast was produced in conjunction with the journal’s “themed issue on Registries in Rheumatological and Musculoskeletal Conditions.”

Click here to access this third-party podcast resource.

Related Videos
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
How to Manage Aspirin-Exacerbated Respiratory Disease
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
© 2024 MJH Life Sciences

All rights reserved.